EMEA-002181-PIP01-17

Key facts

Active substance
  • Pilocarpine (hydrochloride)
  • oxymetazoline (hydrochloride)
Therapeutic area
Ophthalmology
Decision number
P/0333/2017
PIP number
EMEA-002181-PIP01-17
Pharmaceutical form(s)
  • Eye drops, solution
  • Solution
Condition(s) / indication(s)
Treatment of presbyopia
Route(s) of administration
Ophthalmic use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

E-mail: ml-eu_reg_affairs@allergan.com
Tel. +44 (0)1628 4944444

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating